Nexgel Inc WT (NXGLW)

$0.50 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 4.09M
Net Income (ttm) -3.16M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 363
Avg Vol 8,258
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 96%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin;...

Phone: 215 702 8550
Website: nexgel.com
Address:
2150 Cabot Boulevard West, Suite B, Langhorne, United States
Latest News on NXGLW
NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

May 13, 2026, 8:30 AM EDT - 10 hours ago

NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical

NXGLW

NEXGEL To Report First Quarter 2026 Financial Results on May 15th

May 12, 2026, 10:27 AM EDT - 1 day ago

NEXGEL To Report First Quarter 2026 Financial Results on May 15th

NXGLW

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

May 6, 2026, 9:00 AM EDT - 7 days ago

NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors

NXGLW

NexGel appoints Ian Blackman as CFO

2026-04-27T13:38:27.000Z - 16 days ago

NexGel appoints Ian Blackman as CFO

CELU

NEXGEL Transcript: M&A announcement

Apr 21, 2026, 4:30 PM EDT - 22 days ago

NEXGEL Transcript: M&A announcement

NexGel closes acquisition of products from Celularity

2026-04-21T15:06:20.000Z - 22 days ago

NexGel closes acquisition of products from Celularity

CELU

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Apr 17, 2026, 3:37 PM EDT - 26 days ago

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction

Apr 15, 2026, 4:12 PM EDT - 4 weeks ago

NEXGEL Reschedules Shareholder Update Conference Call to April 23rd at 4:30 P.M. ET to Provide Update on Celularity Transaction

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction

Apr 8, 2026, 4:05 PM EDT - 5 weeks ago

NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction

NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

Mar 31, 2026, 4:12 PM EDT - 6 weeks ago

NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity

NexGel price target lowered to $2 from $6 at Maxim

2026-03-12T13:15:47.000Z - 2 months ago

NexGel price target lowered to $2 from $6 at Maxim

NexGel announces terms of agreement of license for products from Celularity

2026-03-12T12:55:45.000Z - 2 months ago

NexGel announces terms of agreement of license for products from Celularity

CELU

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

Mar 12, 2026, 8:45 AM EDT - 2 months ago

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

Celularity reiterates strategic commercialization partnership with NEXGEL

2026-03-12T12:35:15.000Z - 2 months ago

Celularity reiterates strategic commercialization partnership with NEXGEL

CELU

NexGel sign agreement to license, acquire portfolio of products from Celularity

2026-03-10T12:51:55.000Z - 2 months ago

NexGel sign agreement to license, acquire portfolio of products from Celularity

CELU

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

Mar 10, 2026, 8:45 AM EDT - 2 months ago

NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products

NexGel announces financing of $1.797M relating to acquistion

2026-02-10T14:10:54.000Z - 3 months ago

NexGel announces financing of $1.797M relating to acquistion

NexGelRx receives additional investment from Eric Gruntfest, Ariel Imas

2025-12-16T13:10:10.000Z - 5 months ago

NexGelRx receives additional investment from Eric Gruntfest, Ariel Imas

NexGel to spin-off drug delivery program into NexGelRx

2025-12-11T13:15:18.000Z - 5 months ago

NexGel to spin-off drug delivery program into NexGelRx

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

Dec 11, 2025, 8:00 AM EST - 5 months ago

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx

NEXGEL Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 6 months ago

NEXGEL Earnings Call Transcript: Q3 2025

NEXGEL Reports Third Quarter 2025 Financial Results

Nov 11, 2025, 4:10 PM EST - 6 months ago

NEXGEL Reports Third Quarter 2025 Financial Results

NEXGEL Transcript: LD Micro Main Event XIX Investor Conference

Oct 20, 2025, 2:30 PM EDT - 7 months ago

NEXGEL Transcript: LD Micro Main Event XIX Investor Conference

NEXGEL Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 9 months ago

NEXGEL Earnings Call Transcript: Q2 2025

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

Aug 6, 2025, 8:00 AM EDT - 10 months ago

NEXGEL to Report Second Quarter 2025 Financial Results on August 12th

NexGel appoints Steve Ciardiello to board of directors

2025-08-05T12:29:27.000Z - 10 months ago

NexGel appoints Steve Ciardiello to board of directors

SSTK

NexGel prices 413,044 shares at $2.30 in registered direct offering

2025-08-01T12:05:29.000Z - 10 months ago

NexGel prices 413,044 shares at $2.30 in registered direct offering

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

Aug 1, 2025, 8:00 AM EDT - 10 months ago

NEXGEL Announces $950,000 Registered Direct Offering and Concurrent Private Placement

NexGel, STADA announce expansion of partnership for North America

2025-07-14T13:05:37.000Z - 10 months ago

NexGel, STADA announce expansion of partnership for North America

NEXGEL and STADA AG Announce Expansion of Partnership for North America

Jul 14, 2025, 9:00 AM EDT - 10 months ago

NEXGEL and STADA AG Announce Expansion of Partnership for North America

NEXGEL Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings Call Transcript: Q1 2025

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

May 9, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

NEXGEL Transcript: Planet MicroCap Showcase: VEGAS 2025

Apr 23, 2025, 12:30 PM EDT - 1 year ago

NEXGEL Transcript: Planet MicroCap Showcase: VEGAS 2025

NEXGEL Earnings Call Transcript: Q4 2024

Mar 24, 2025, 4:30 PM EDT - 1 year ago

NEXGEL Earnings Call Transcript: Q4 2024

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Mar 24, 2025, 4:05 PM EDT - 1 year ago

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Mar 19, 2025, 9:00 AM EDT - 1 year ago

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

Feb 13, 2025, 9:00 AM EST - 1 year ago

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

NexGel expects to generate at least $13M in revenue in FY25

2025-01-22T14:10:46.000Z - 1 year ago

NexGel expects to generate at least $13M in revenue in FY25

NexGel issues letter to shareholders

2025-01-22T14:05:27.000Z - 1 year ago

NexGel issues letter to shareholders

NexGel sees Q4 revenue approximately $3M

2025-01-22T14:05:10.000Z - 1 year ago

NexGel sees Q4 revenue approximately $3M

NexGel appoints McGuire as Chief Financial Officer

2025-01-02T14:05:24.000Z - 1 year ago

NexGel appoints McGuire as Chief Financial Officer

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

Jan 2, 2025, 9:00 AM EST - 1 year ago

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

NEXGEL Transcript: IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 2024

Dec 10, 2024, 10:30 AM EST - 1 year ago

NEXGEL Transcript: IAccess Alpha–Buyside Best Ideas Winter Virtual Conference 2024

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Nov 13, 2024, 4:40 PM EST - 1 year ago

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

NEXGEL Earnings Call Transcript: Q3 2024

Nov 13, 2024, 4:30 PM EST - 1 year ago

NEXGEL Earnings Call Transcript: Q3 2024

NexGel announces $2M registered direct offering

2024-11-11T22:45:07.000Z - 1 year ago

NexGel announces $2M registered direct offering

NEXGEL Announces $2,000,000 Registered Direct Offering

Nov 11, 2024, 5:35 PM EST - 1 year ago

NEXGEL Announces $2,000,000 Registered Direct Offering

NEXGEL to Participate in Upcoming October Investor Conferences

Oct 11, 2024, 9:00 AM EDT - 1 year ago

NEXGEL to Participate in Upcoming October Investor Conferences

NexGel expects Q3 revenue approx $2.85M

2024-10-10T13:05:57.000Z - 1 year ago

NexGel expects Q3 revenue approx $2.85M

NexGel appoints Kip Crecca to Scientific Advisory Board

2024-10-05T08:46:38.000Z - 1 year ago

NexGel appoints Kip Crecca to Scientific Advisory Board

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

Oct 4, 2024, 9:00 AM EDT - 1 year ago

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

NexGel announces strategic partnership with James Maslow

2024-09-18T13:05:31.000Z - 1 year ago

NexGel announces strategic partnership with James Maslow

NEXGEL Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 1 year ago

NEXGEL Earnings Call Transcript: Q2 2024

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

Aug 14, 2024, 4:25 PM EDT - 1 year ago

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Aug 12, 2024, 9:15 AM EDT - 1 year ago

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

Jul 18, 2024, 9:15 AM EDT - 1 year ago

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

Jul 8, 2024, 4:05 PM EDT - 2 years ago

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

Jun 11, 2024, 8:40 AM EDT - 2 years ago

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

NEXGEL Acquires International Beauty Brand, Silly George

May 16, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Acquires International Beauty Brand, Silly George

NEXGEL Earnings Call Transcript: Q1 2024

May 13, 2024, 4:30 PM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q1 2024

NEXGEL Earnings Call Transcript: Q4 2023

Apr 1, 2024, 8:30 AM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q4 2023

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

Apr 1, 2024, 7:50 AM EDT - 2 years ago

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Mar 21, 2024, 9:00 AM EDT - 2 years ago

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

NEXGEL Transcript: iAccess Alpha Best Ideas Spring Virtual Conference

Mar 12, 2024, 1:30 PM EDT - 2 years ago

NEXGEL Transcript: iAccess Alpha Best Ideas Spring Virtual Conference

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

Mar 4, 2024, 8:30 AM EST - 2 years ago

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

Jan 9, 2024, 8:30 AM EST - 2 years ago

NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

Dec 11, 2023, 8:00 AM EST - 2 years ago

NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America

NEXGEL Earnings Call Transcript: Q3 2023

Nov 13, 2023, 4:30 PM EST - 2 years ago

NEXGEL Earnings Call Transcript: Q3 2023

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

Nov 13, 2023, 4:05 PM EST - 2 years ago

NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

Sep 26, 2023, 9:49 AM EDT - 2 years ago

NEXGEL to Participate in the LD Micro Main Event XVI on October 3rd

NEXGEL Earnings Call Transcript: Q2 2023

Aug 14, 2023, 4:30 PM EDT - 2 years ago

NEXGEL Earnings Call Transcript: Q2 2023

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

Aug 2, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Report Second Quarter 2023 Financial Results on August 14th

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

Jul 19, 2023, 9:10 AM EDT - 3 years ago

NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North America

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

Jun 15, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in Maxim Group's Virtual Healthcare Conference on June 20th

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

May 24, 2023, 9:00 AM EDT - 3 years ago

NEXGEL to Participate in the LD Micro Invitational XIII on June 6th

NEXGEL Earnings Call Transcript: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q1 2023

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

May 9, 2023, 9:15 AM EDT - 3 years ago

NEXGEL to Report First Quarter 2023 Financial Results on May 15th

NEXGEL Earnings Call Transcript: Q4 2022

Mar 27, 2023, 4:30 PM EDT - 3 years ago

NEXGEL Earnings Call Transcript: Q4 2022

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 27, 2023, 4:05 PM EDT - 3 years ago

NEXGEL Reports Fourth Quarter and Full Year 2022 Financial Results

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

Mar 15, 2023, 7:30 AM EDT - 3 years ago

NEXGEL to Report Fourth Quarter and Full Year 2022 Financial Results on March 27th

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

Mar 7, 2023, 7:30 AM EST - 3 years ago

NEXGEL Partners with Former Major League Lacrosse Player, Greg “The Beast” Gurenlian, and The Face-Off Academy to Fight Turf Burn with Turfguard

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

Mar 2, 2023, 8:30 AM EST - 3 years ago

NEXGEL Acquires 50% Interest in Newly Formed Joint Venture with C.G. Laboratories for Converting and Packaging Business

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

Jan 17, 2023, 7:30 AM EST - 3 years ago

NEXGEL Appoints Scott Henry, CFA to Board of Directors and Audit Committee

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

Dec 8, 2022, 7:30 AM EST - 3 years ago

NEXGEL Launches Turfguard to Treat Painful Turf Burns and Protect Sports-Related Wounds

NEXGEL Announces Share Repurchase Program

Dec 7, 2022, 7:30 AM EST - 3 years ago

NEXGEL Announces Share Repurchase Program

NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET

Dec 1, 2022, 11:00 AM EST - 3 years ago

NEXGEL to Host Fireside Chat with CEO Adam Levy on December 14th at 11:00 a.m. ET